首页> 外文期刊>Platelets >Heparin-induced thrombocytopenia leading to stroke, lower extremity arterial occlusive disease, and skin necrosis: A case report
【24h】

Heparin-induced thrombocytopenia leading to stroke, lower extremity arterial occlusive disease, and skin necrosis: A case report

机译:肝素诱导的血小板减少症导致中风,下肢动脉闭塞性疾病和皮肤坏死:一例报告

获取原文
获取原文并翻译 | 示例
       

摘要

Enoxaparin sodium is a low molecular weight heparin (LMWH) used to treat and prevent deep venous thrombosis (DVT). The common complications related to the use of heparin are bleeding, allergic reaction, and osteoporosis. A less common complications are thrombocytopenia and thromboembolism that may not be generally recognized. We present a case of low molecular weight (LMW) heparin-induced thrombocytopenia (HIT) causing stroke, lower extremity arterial occlusion, and skin necrosis. Monitoring the platelet count is essential for early diagnosis of HIT. All patients who undergo heparinization should have a baseline platelet count done before the regimen is started and should be monitored closely especially during the first weeks of treatment.
机译:依诺肝素钠是一种低分子量肝素(LMWH),用于治疗和预防深静脉血栓形成(DVT)。与使用肝素有关的常见并发症是出血,过敏反应和骨质疏松症。不太常见的并发症是血小板减少症和血栓栓塞症,这可能是普遍不认识的。我们介绍一例低分子量(LMW)肝素诱导的血小板减少症(HIT),引起中风,下肢动脉闭塞和皮肤坏死。监测血小板计数对于HIT的早期诊断至关重要。所有接受肝素化治疗的患者均应在开始治疗方案之前进行基线血小板计数,并应密切监测,尤其是在治疗的最初几周。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号